1. Home
  2. FE vs DGX Comparison

FE vs DGX Comparison

Compare FE & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FE
  • DGX
  • Stock Information
  • Founded
  • FE 1996
  • DGX 1967
  • Country
  • FE United States
  • DGX United States
  • Employees
  • FE N/A
  • DGX N/A
  • Industry
  • FE Electric Utilities: Central
  • DGX Medical Specialities
  • Sector
  • FE Utilities
  • DGX Health Care
  • Exchange
  • FE Nasdaq
  • DGX Nasdaq
  • Market Cap
  • FE 23.9B
  • DGX 20.5B
  • IPO Year
  • FE N/A
  • DGX 1996
  • Fundamental
  • Price
  • FE $46.00
  • DGX $176.99
  • Analyst Decision
  • FE Buy
  • DGX Buy
  • Analyst Count
  • FE 15
  • DGX 15
  • Target Price
  • FE $48.67
  • DGX $194.07
  • AVG Volume (30 Days)
  • FE 4.8M
  • DGX 1.1M
  • Earning Date
  • FE 10-22-2025
  • DGX 10-21-2025
  • Dividend Yield
  • FE 3.88%
  • DGX 1.81%
  • EPS Growth
  • FE 48.81
  • DGX 14.49
  • EPS
  • FE 2.31
  • DGX 8.51
  • Revenue
  • FE $14,283,000,000.00
  • DGX $10,850,000,000.00
  • Revenue This Year
  • FE $10.61
  • DGX $11.17
  • Revenue Next Year
  • FE $3.60
  • DGX $3.48
  • P/E Ratio
  • FE $19.88
  • DGX $20.73
  • Revenue Growth
  • FE 7.74
  • DGX 13.74
  • 52 Week Low
  • FE $37.58
  • DGX $148.70
  • 52 Week High
  • FE $48.20
  • DGX $197.55
  • Technical
  • Relative Strength Index (RSI)
  • FE 49.44
  • DGX 41.73
  • Support Level
  • FE $45.56
  • DGX $174.33
  • Resistance Level
  • FE $46.30
  • DGX $180.04
  • Average True Range (ATR)
  • FE 0.70
  • DGX 4.49
  • MACD
  • FE -0.20
  • DGX -0.54
  • Stochastic Oscillator
  • FE 27.82
  • DGX 11.46

About FE FirstEnergy Corp.

FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: